According to AnaptysBio's latest financial reports the company's current revenue (TTM ) is A$0.14 Billion. an increase over the revenue in the year 2023 that were of A$25.18 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 | A$0.14 B | 482.75% |
2023 | A$25.18 M | 66.59% |
2022 | A$15.11 M | -82.65% |
2021 | A$87.14 M | -10.66% |
2020 | A$97.53 M | 753.63% |
2019 | A$11.42 M | 60.99% |
2018 | A$7.09 M | -44.59% |
2017 | A$12.8 M | -44.66% |
2016 | A$23.14 M | -4.04% |
2015 | A$24.11 M |